BSE Live
Mar 25, 13:07Prev. Close
4664.80
Open Price
4701.00
Bid Price (Qty.)
4726.80 (2)
Offer Price (Qty.)
4735.00 (2)
NSE Live
Mar 25, 13:07Prev. Close
4659.50
Open Price
4674.00
Bid Price (Qty.)
4729.50 (3)
Offer Price (Qty.)
4735.00 (1)
| Balance Sheet of Pfizer (in Rs. Cr.) | Nov 08 | Nov 07 | Nov 06 | |
| 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||
| SHAREHOLDER'S FUNDS | ||||
| Equity Share Capital | 29.84 | 29.84 | 29.84 | |
| Total Share Capital | 29.84 | 29.84 | 29.84 | |
| Reserves and Surplus | 871.25 | 619.88 | 375.89 | |
| Total Reserves and Surplus | 871.25 | 619.88 | 375.89 | |
| Total Shareholders Funds | 901.09 | 649.72 | 405.73 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 3.01 | 4.50 | 2.26 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 3.01 | 4.50 | 2.26 | |
| CURRENT LIABILITIES | ||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 108.18 | 92.05 | 129.08 | |
| Other Current Liabilities | 14.50 | 14.55 | 16.39 | |
| Short Term Provisions | 73.87 | 111.14 | 94.69 | |
| Total Current Liabilities | 196.55 | 217.74 | 240.16 | |
| Total Capital And Liabilities | 1,100.65 | 871.97 | 648.15 | |
| ASSETS | ||||
| NON-CURRENT ASSETS | ||||
| Tangible Assets | 50.61 | 60.01 | 65.00 | |
| Intangible Assets | 0.16 | 0.16 | 0.16 | |
| Capital Work-In-Progress | 32.30 | 10.24 | 1.60 | |
| Fixed Assets | 83.06 | 70.41 | 66.76 | |
| Non-Current Investments | 0.50 | 0.50 | 0.00 | |
| Deferred Tax Assets [Net] | 25.68 | 17.48 | 16.62 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 2.93 | 13.34 | |
| Total Non-Current Assets | 109.25 | 91.32 | 96.72 | |
| CURRENT ASSETS | ||||
| Current Investments | 0.00 | 0.00 | 0.00 | |
| Inventories | 124.99 | 95.85 | 99.31 | |
| Trade Receivables | 60.31 | 61.69 | 69.48 | |
| Cash And Cash Equivalents | 543.65 | 479.91 | 306.94 | |
| Short Term Loans And Advances | 261.96 | 142.69 | 70.90 | |
| OtherCurrentAssets | 0.50 | 0.50 | 4.80 | |
| Total Current Assets | 991.41 | 780.64 | 551.43 | |
| Total Assets | 1,100.65 | 871.97 | 648.15 | |
| OTHER ADDITIONAL INFORMATION | ||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||
| Contingent Liabilities | 68.69 | 105.72 | 59.34 | |
| BONUS DETAILS | ||||
| Bonus Equity Share Capital | 19.11 | 19.11 | 19.11 | |
| NON-CURRENT INVESTMENTS | ||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.50 | 0.50 | 0.00 | |
| CURRENT INVESTMENTS | ||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011
25.03.2026
25.03.2026
25.03.2026
24.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth